Abstract
The effect of various GnRH analogues, and their conjugates on proliferation, clonogenicity and cell cycle phase distribution of MCF-7 and Ishikawa human cancer cell lines was studied. GnRH-III, a sea lamprey GnRH analogue reduced cell proliferation by 35% and clonogenicity by 55%. Structural modifications either decreased, or did not alter biological activity. Conjugation of GnRH analogues including MI-1544, MI-1892, and GnRH-III with poly(N-vinylpyrrolidone-co-maleic acid) (P) through a tetrapeptide spacer GFLG(X) substantially increased the inhibitory effect of the GnRH analogues. The conjugate P-X-GnRH-III induced significant accumulation of cells in the G2/M phase; from 8% to 15.6% at 24 h and 9.8% to 15% at 48 h. It was concluded that conjugation of various GnRH analogues substantially enhanced their antiproliferative activity, strongly reduced cell clonogenicity and retarded cell progression through the cell division cycle at the G2/M phase.
| Original language | English |
|---|---|
| Pages (from-to) | 275-285 |
| Number of pages | 11 |
| Journal | Cell Proliferation |
| Volume | 33 |
| Issue number | 5 |
| DOIs | |
| State | Published - 2000 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Cell Biology
Cite this
Influence on antiproliferative activity of structural modification and conjugation of gonadotropin-releasing hormone (GnRH) analogues. / Kálnay, A.; Pályi, I.; Vincze, B.; Mihalik, R.; Mezõ, I.; Pató, J.; Seprõdi, J.; Lovas, Sándor; Murphy, R. F.
In: Cell Proliferation, Vol. 33, No. 5, 2000, p. 275-285.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Influence on antiproliferative activity of structural modification and conjugation of gonadotropin-releasing hormone (GnRH) analogues
AU - Kálnay, A.
AU - Pályi, I.
AU - Vincze, B.
AU - Mihalik, R.
AU - Mezõ, I.
AU - Pató, J.
AU - Seprõdi, J.
AU - Lovas, Sándor
AU - Murphy, R. F.
PY - 2000
Y1 - 2000
N2 - The effect of various GnRH analogues, and their conjugates on proliferation, clonogenicity and cell cycle phase distribution of MCF-7 and Ishikawa human cancer cell lines was studied. GnRH-III, a sea lamprey GnRH analogue reduced cell proliferation by 35% and clonogenicity by 55%. Structural modifications either decreased, or did not alter biological activity. Conjugation of GnRH analogues including MI-1544, MI-1892, and GnRH-III with poly(N-vinylpyrrolidone-co-maleic acid) (P) through a tetrapeptide spacer GFLG(X) substantially increased the inhibitory effect of the GnRH analogues. The conjugate P-X-GnRH-III induced significant accumulation of cells in the G2/M phase; from 8% to 15.6% at 24 h and 9.8% to 15% at 48 h. It was concluded that conjugation of various GnRH analogues substantially enhanced their antiproliferative activity, strongly reduced cell clonogenicity and retarded cell progression through the cell division cycle at the G2/M phase.
AB - The effect of various GnRH analogues, and their conjugates on proliferation, clonogenicity and cell cycle phase distribution of MCF-7 and Ishikawa human cancer cell lines was studied. GnRH-III, a sea lamprey GnRH analogue reduced cell proliferation by 35% and clonogenicity by 55%. Structural modifications either decreased, or did not alter biological activity. Conjugation of GnRH analogues including MI-1544, MI-1892, and GnRH-III with poly(N-vinylpyrrolidone-co-maleic acid) (P) through a tetrapeptide spacer GFLG(X) substantially increased the inhibitory effect of the GnRH analogues. The conjugate P-X-GnRH-III induced significant accumulation of cells in the G2/M phase; from 8% to 15.6% at 24 h and 9.8% to 15% at 48 h. It was concluded that conjugation of various GnRH analogues substantially enhanced their antiproliferative activity, strongly reduced cell clonogenicity and retarded cell progression through the cell division cycle at the G2/M phase.
UR - http://www.scopus.com/inward/record.url?scp=0033735761&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033735761&partnerID=8YFLogxK
U2 - 10.1046/j.1365-2184.2000.00180.x
DO - 10.1046/j.1365-2184.2000.00180.x
M3 - Article
C2 - 11063130
AN - SCOPUS:0033735761
VL - 33
SP - 275
EP - 285
JO - Cell Proliferation
JF - Cell Proliferation
SN - 0960-7722
IS - 5
ER -